Results
1 -
10 of
49
(Click
here to explore results)
- Allosterism in Drug Discovery, CHAPTER 16 Allosteric Binding in the Serotonin Transporter – Pharmacology, Structure, Function and Potential Use as a Novel Drug Target. Claus J. Loland, Connie Sanchez, Per Plenge, Klaus P. Bøgesø, Benny Bang-Andersen
, 2017
, Pages 360-380
- Biomedical Imaging: The Chemistry of Labels, Probes and Contrast Agents, Chapter 3 Recent Developments in PET and SPECT Radioligands for CNS Imaging. David Alagille, Ronald M. Baldwin, Gilles D. Tamagnan
, 2012
, Pages 49-143
- Drug Discovery for Psychiatric Disorders, CHAPTER 8 Beyond SSRIs: Second-generation Reuptake Inhibitors for the Treatment of Depression. Peter T. Gallagher
, 2012
, Pages 184-225
- Drug Discovery for Psychiatric Disorders, CHAPTER 7 The Neurobiology of Depression and Anxiety: How Do We Change from Models of Drug Efficacy to Understanding Mood and Anxiety Disorders?. Georgia E. Hodes, Scott J. Russo
, 2012
, Pages 159-183
- Biological Treatment of Industrial Wastewater, CHAPTER 13 Membrane Bioreactors for Separation of Persistent Organic Pollutants From Industrial Effluents. Aisha Zaman, Priya Banerjee, Aniruddha Mukhopadhyay, Papita Das, Dipankar Chattopadhyay
, 2022
, Pages 257-293
- Acute Brain Impairment: Scientific Discoveries and Translational Research, Chapter 14 Testing and Mechanisms of Neuroprotective Agents for Cerebral Ischemic Injury in Clinical Trials, 2010–2016. S. L. Grupke, J. F. Fraser
, 2018
, Pages 242-262
- New Synthetic Technologies in Medicinal Chemistry, Chapter 4 Microwave Assisted Chemistry. Rachel Osborne
, 2012
, Pages 63-89
- Drug Discovery for Psychiatric Disorders, CHAPTER 12 Neuropeptide Receptors: Novel Therapeutic Targets for Depression and Anxiety Disorders. Shigeyuki Chaki, Kosuke Kanuma
, 2012
, Pages 300-330
- Acute Brain Impairment: Scientific Discoveries and Translational Research, Contents
, 2018
, Pages 9-18
- Allosterism in Drug Discovery, Subject Index
, 2017
, Pages 427-437